January 30, 2019
BAY43-9006 Phase II Study for Renal Cell Carcinoma
Read More
January 30, 2019
Study of Peretinoin for Suppressing Recurrence of HCV-positive HCC
Read More
January 30, 2019
Study of Peretinoin for Suppressing Recurrence of HCV-positive HCC
Read More
January 30, 2019
A Phase 3, Comparative Study of Asunaprevir and Daclatasvir Combination Therapy Versus Telaprevir Therapy in Japanese HCV Subjects
Read More
January 30, 2019
Japanese Pegylated Interferon (PegIFN) Alfa-2b/Ribavirin (RBV) Combination Trial
Read More
January 30, 2019
UNITY 3: A Japanese Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 in Subjects With Genotype 1 Chronic Hepatitis C
Read More
January 30, 2019
Trial of Pegasys® in Patients With Chronic Hepatitis C
Read More
January 30, 2019
This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis C
Read More
January 30, 2019
An Open-Label Rollover Study of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B Infection
Read More
January 30, 2019
Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial
Read More
January 30, 2019
Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)
Read More
January 30, 2019
Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)
Read More
Load More
X